Víctor Zegarra
Consultant in Civil, Commercial Law, and Dispute Resolution
legal@unionandina.com
Víctor is a consultant whose professional practice is focused on the prevention and resolution of disputes, specializing in contractual and commercial disputes, civil liability, and compensation. He has extensive experience in both judicial and arbitration proceedings, representing companies in defending their interests before various courts.
Throughout his career, he has provided strategic advice to companies across multiple sectors, leading conflict resolution processes and defending complex disputes. Previously, he was a Senior Associate at Cavero-Blumenfeld, Llosa & R. La Rosa Abogados.
Education
• Specialization in Arbitration in State Procurement from the Pontificia Universidad Católica del Perú
• Specialization in State Procurement Management from the Pontificia Universidad Católica del Perú
• Specialization in International and Investment Arbitration from the Universidad del Pacífico
• Master’s degree in Corporate Law from the Universidad de Ciencas Aplicadas
• Law degree from the Pontificia Universidad Católica del Perú
Latest 3 articles on our blog
3 trends in assistive technology patents
The average global age is increasing. Today more and more people are in their 60s and this opened a new market associated with assistive technology. It is a growing niche not only in terms of global sales volume, but also in terms of invention and patent registration....
Orange economy: How much do creative industries produce in Peru?
When the visual and performing arts are mentioned, there is always talk about the cultural contribution and the importance of the copyright of the works, but rarely do they pay attention to the impact that these creative industries can have on the economy of a...
Why are COVID-19 vaccine patents at the center of the debate?
Any of the COVID-19 vaccines, Pfizer/BioNTech, Moderna, AstraZeneca or Sinopharm, has a registered patent. It is an invention protection that is now at the center of the global debate. Patents for COVID-19 vaccines offer recognition to the entire research and...